Fact CheckerSign in

NCT07165821Completed

Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic Patients

Source: ClinicalTrials.gov · Last updated 10 Sept 2025

Brief summary (registry, in English)

This quasi-experimental two-group pretest-posttest study examined the effects of an interpersonal communication skills training program on medication adherence in patients with schizophrenia, measured at pre-intervention, post-intervention, and one-month follow-up. Research Hypotheses 1. The experimental group receiving the interpersonal communication skills training program will show higher mean treatment adherence scores post-intervention and at one-month follow-up compared to baseline. 2. The experimental group will show higher mean treatment adherence scores post-intervention and at one-month follow-up than the control group receiving routine nursing care.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
24 Aug 2025
Start date
1 Jun 2024
Primary completion date
30 Sept 2024
Lead sponsor
Suranaree University of Technology
NCT number
NCT07165821

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 1 Jun 2024 to the primary completion date, 30 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with other psychiatric comorbidities(e.g., depression, bipolar disorder, anxiety, or substance-induced psychosis)

Who the study is looking for

  • Male patients aged 20-59 with an ICD-10 schizophrenia diagnosis(F20.0-F20.9).
  • History of psychiatric readmission due to medication non-adherence
  • Mild psychiatric symptoms(Thai BPRS score ≤ 36).
  • Poor interpersonal communication skills(score ≤ 1.50 on Thiengviriya et al.'s assessment tool
  • Low to moderate medication adherence(score ≤ 42 on Uthaiphan \& Daengdomyut's scale
  • Able to read, write, speak, and without hearing/visual impairments.
  • Had a primary caregiver post-discharge.
  • Provided informed consent voluntarily.

Age in the registry: 20 years to 59 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prasrimahabhodi Psychiatric Hospital, ,Thailand
Coordinator of this site? Confirm its status
Nai MuangThailandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.